0 patents currently held, every record listed here
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
This portfolio holds none of the 5 US patents in force on its record. from the record
Of the 5 now held by other companies, 5 name Gen Probe Incorporated as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end
When these terms end
Each bar runs from grant to computed term end. 2017 to 2043.
US 11,566,294
Method for detecting the presence of a hypervirulent Clostridium difficile strain
May 5, 2039
US 12,716,088
Method and System For Performing a Cumulative Nucleic Acid Amplification Reaction
Jan 1, 2043
202220272032203720422043
6 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends May 2039 · High confidence
The newest of the three, granted 2023. It anchors the portfolio to 2039, later than anything else here.
now held by Gen-Probe Incorporated
Also notable
Ends Apr 2033 · High confidence
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2033.
now held by Gen-Probe Incorporated
Also notable
Ends Aug 2035 · High confidence
Granted 2020. Computed term ends 2035.
now held by Gen-Probe Incorporated
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first.
Also on record: 5 patents in force now held by others · 6 applications pending · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.